09/18/2026
In a recent Medscape Medical News article, Joshua Neumiller, PharmD, CDCES, discusses the increased risk of prediabetes and diabetes among people with HIV and how some antiretroviral therapies can contribute to insulin resistance and elevated blood glucose.
He also highlights an important consideration for clinicians: people with both HIV and diabetes face heightened cardiovascular and kidney risks, making risk reduction a key treatment objective.
The full article explores what clinicians should know about monitoring and managing diabetes in people with HIV — and why comprehensive, multidisciplinary care matters.